Search - tctmd.com

Displaying 41 - 60 of 82

Sort: Relevancy | Date

News Conference News TCT 2018

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

Yael L. Maxwell

September 25, 2018

News Opinion Editor's Corner TCT 2018

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

Shelley Wood

September 23, 2018

News Conference News TCT 2018

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Yael L. Maxwell

September 23, 2018

Presentation TCT 2018

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Presenter: Alexander Lauten

September 23, 2018

News Opinion Off Script TCT 2017

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

Kwan S. Lee

November 01, 2017

News Conference News TCT 2017

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

Michael O'Riordan

October 31, 2017

Presentation TCT 2017

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

Presenter: Hemal Gada

October 31, 2017

Presentation TCT 2017

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

Presenter: John K. Forrest

October 31, 2017

Presentation TCT 2017

The Evolut R Low-risk Trial

Presenter: Jeffrey J. Popma

October 30, 2017

Presentation TCT 2017

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Presenter: Julinda Mehilli, Giulio G. Stefanini, Dariusz Dudek

October 30, 2017

Presentation TCT 2017

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

Presenter: Bernard De Bruyne, Evelyn S. Regar, Giora Weisz

October 30, 2017

News Opinion Off Script TCT 2017

Off Script: Welcome to TCT 2017 in the Mile High City

Kwan S. Lee

October 29, 2017

Presentation TCT 2016

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Presenter: Eberhard Grube, James B. Hermiller Jr., Jeffrey J. Popma

November 01, 2016

‘Promising’ SENTINEL Cerebral Protection in TAVR Collects Debris but Misses Primary Endpoint

News Conference News TCT 2016

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Shelley Wood

November 01, 2016

Presentation TCT 2016

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Presenter: Dean J. Kereiakes, Pieter C. Smits

October 30, 2016

Presentation TCT 2016

Evolution of the Nurse/Tech Role in the Cath Lab

Presenter: Regina Deible, Mary K. Egan

October 30, 2016

Presentation TCT 2016

Evolution of the Nurse/Tech Team

Presenter: Regina Deible, Mary K. Egan, Christopher M. Nelson

October 30, 2016

Presentation TCT 2016

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Presenter: A. Pieter Kappetein

October 30, 2016

Presentation TCT 2015

Evolution of the Minimalist Approach: A Generalizable Strategy to Improve Procedural Efficiency and Maintain Optimal Outcomes

Presenter: Ganesh Manoharan, Mathew Williams, Helene Eltchaninoff

October 15, 2015

Presentation TCT 2015

FDA-Approved or US IDE Studies: EVOLUT R Procedural Considerations and Case Examples

Presenter: Ariel Finkelstein, Ganesh Manoharan, Stephen J.D. Brecker

October 14, 2015

Advertisement

NEOPRO: Two Next-Gen TAVR Valves Show Promise at 30 Days

TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights

SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia

Evolution of Caval Valves (CAVI) Last Resort TR Patients Technology and Clinical Updates

Off Script: Connecting and Collaborating in the Global Village of Interventional Cardiology

One in Six Patients With LBBB Post-TAVR Develop Atrioventricular Block

EVOLUT R Procedural Pearls (Including how NOT to Need a New Pacemaker)

EVOLUT R TAVR Technology Review (Including EVOLUT 34mm and PRO) and Clinical Program Updates

The Evolut R Low-risk Trial

Tradeoffs of Embolic Protection and Sealing vs Restenosis: Utility of the Micronet MGuard Stent for MI, SVG, Aneurysms, and More

Featured Lecture: Technological Evolution of Cath-lab Technologies: Impact of Advanced Imaging Diagnostics on Procedural Flow and Interventional Procedures

Off Script: Welcome to TCT 2017 in the Mile High City

Evolut R and 2.0: Design Features, Special Attributes, and Clinical Trial Program

Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint

Stent Design and Comprehensive Data Review: Platinum Chromium Everolimus-Eluting Stents - Evolution From the Fluoropolymer-Based Promus Element to the Bioabsorbable Polymer-Based Synergy

Evolution of the Nurse/Tech Role in the Cath Lab

Evolution of the Nurse/Tech Team

The Evolution of Therapies for Coronary Artery Disease and Valve Disorders in My Lifetime

Evolution of the Minimalist Approach: A Generalizable Strategy to Improve Procedural Efficiency and Maintain Optimal Outcomes

FDA-Approved or US IDE Studies: EVOLUT R Procedural Considerations and Case Examples

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content